Vaylen vs Brello: Compounded GLP-1 options compared

Vaylen vs Brello: quick verdict. Vaylen is a cash-pay telehealth program that publishes prepaid compounded GLP-1 plans from $83.25/mo and offers a full refund if a clinician declines; Brello had no verified pricing or plan details on the captured page and requires confirmation of eligibility, pricing, pharmacy and state coverage before enrolling.

See Vaylen plans and pricing

How they differ: pricing, transparency, and verification

Compare Vaylen and Brello directly across the facts captured. Vaylen publishes explicit prepaid 12-month rates and a two-tier monthly option for semaglutide and tirzepatide, and it states a refund if a clinician declines. Brello’s landing evidence did not publish verifiable pricing, eligibility, pharmacy, state coverage, or renewal terms in the captured material, so those items must be confirmed with Brello before enrollment.

Distinctive difference 1: pricing structure and prepay model

Vaylen: Semaglutide injections from $83.25/mo on a 12-month plan billed upfront, oral semaglutide $99/mo prepaid, and tirzepatide $149/mo prepaid. Vaylen also publishes month-to-month headline rates (for example semaglutide $224/mo) and states each 12-month rate is billed in a single charge. Vaylen is explicit that you pay before clinician review and that you receive a full refund for the billing cycle if the clinician declines.

Brello: The captured landing-page evidence did not verify pricing or terms. The source warns that pricing, eligibility, pharmacy, state coverage and renewal terms may change and should be confirmed.

Check Brello eligibility and current offers

Distinctive difference 2: medication formats and molecules offered

Vaylen: Offers compounded semaglutide in weekly injection and daily oral tablet formats plus weekly tirzepatide on one platform, allowing clinicians to switch formats or molecules without changing providers according to its materials.

Brello: The captured evidence did not include a verified description of which molecules or formats are available; treatment availability must be confirmed with a clinician.

Distinctive difference 3: clinician review timing and refund policy

Vaylen: States a board-certified U.S. clinician reviews health forms within 24 hours. Vaylen is explicit that you prepay and then complete a questionnaire; if the clinician determines GLP-1 medication is not medically appropriate, Vaylen states you receive a full refund for that billing cycle.

Brello: The captured landing-page evidence did not include verified clinician-review timing or refund terms. The recommendation in the captured record is to confirm eligibility, total cost, renewal terms and state availability before enrollment.

Distinctive difference 4: regulatory disclosures and transparency

Vaylen: Repeatedly discloses that its offerings are compounded medications, which are not FDA-approved finished products and are not reviewed by the FDA for safety, effectiveness or quality. Vaylen also states clinicians are licensed in all 50 states via a named partner and that the platform is LegitScript certified.

Brello: The captured evidence includes the general note that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. No further regulatory or licensing details were captured.

Comparison table: Vaylen vs Brello

Criteria	Vaylen	Brello
Starting price	$83.25/mo on 12-month semaglutide plan (prepaid)	Not verified on captured page
Formats / molecules	Semaglutide injections, oral semaglutide tablets, tirzepatide injections	Not verified; must confirm
Payment model	Cash-pay; prepaid 12-month rates billed upfront; month-to-month options listed	Not verified on captured page
Clinician review & timing	Clinician review within 24 hours after prepay; refund if declined	Not captured; confirm with provider
Regulatory note	Compounded medications are not FDA-approved finished products	Medication-specific approval status must be confirmed; branded and compounded are not interchangeable

Practical implications and what the captured evidence supports

If you prioritize published prepaid pricing, a platform that offers both injections and an oral tablet plus tirzepatide and an explicit refund if a clinician declines, the captured evidence supports Vaylen as a clear choice. If you need confirmed current pricing, state coverage, pharmacy, renewal terms or other live-offer details for Brello, the captured evidence instructs you to confirm those items directly with Brello before enrolling.

Compare Vaylen medication formats

Final comparison and choosing

Vaylen vs Brello: based solely on the captured evidence, Vaylen publishes specific prepaid rates, discloses compounded status, lists formats and molecules, and documents a refund if a clinician declines. Brello had no verified pricing or plan details on the captured landing page and the captured record recommends confirming eligibility, medication, total cost, renewal terms and state availability before enrollment.

Start with Vaylen pricing and terms

Contact Brello to confirm current details

Choose based on the captured facts

Choose Vaylen if you want published prepaid GLP-1 plans from $83.25/mo, multiple formats including an oral tablet, a stated clinician review within 24 hours and a full refund if a clinician declines. Choose Brello if you first confirm eligibility, medication options, current pricing, renewal terms and state availability directly with Brello because those items were not verified on the captured page.